FOSRENOL(R) Data Show Evidence Of Trends Towards Improved Bone Formation In CKD Stage 5 Patients, New Data Presented At ASN Meeting

... Treatment with the phosphate binder FOSRENOL(R) (lanthanum carbonate) was associated with slight improvements in bone formation in chronic kidney disease (CKD) Stage 5 patients with hyperphosphatemia (high phosphorus levels in the blood), according to long- term (two-year) data presented at the American Society of Nephrology (ASN) meeting. [click link for full article] ...